COVID-19 and vitamin D—Is there a link and an opportunity for intervention?
2020; American Physiological Society; Volume: 318; Issue: 5 Linguagem: Inglês
10.1152/ajpendo.00138.2020
ISSN1522-1555
Autores Tópico(s)Vitamin C and Antioxidants Research
ResumoLetter to the EditorCOVID-19 and vitamin D—Is there a link and an opportunity for intervention?Hrvoje JakovacHrvoje JakovacDepartment of Physiology and Immunology, Medical Faculty, University of Rijeka, Rijeka, CroatiaPublished Online:16 Apr 2020https://doi.org/10.1152/ajpendo.00138.2020MoreSectionsPDF (44 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInWeChat to the editor: The recent outbreak and rapid spreading of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a global threat and primary concern worldwide, with a still uncertain outcome. With the lack of effective therapy, chemoprevention, and vaccination, focusing on the immediate repurposing of existing drugs gives hope of curbing the pandemic. Here, I underline that so far there are no reports on the vitamin D status among affected persons. On the other hand, a large number of well-established data showed antiviral effects of vitamin D, which can interfere directly with viral replication, but also can act in an immunomodulatory and anti-inflammatory way (7). The latter effects could be crucial for their assumptive beneficial effects during SARS-CoV-2 infection, since it seems that SARS-CoV-2 initially uses immune evasion mechanisms, which in some patients is followed by immune hyperreaction and cytokine storm (1), as a common pathogenic mechanism of acute respiratory disease syndrome (ARDS) and systemic inflammatory response syndrome (SIRS) development, regardless of the etiological factor. In that sense, the protective effect of vitamin D has been reported in many conditions associated with pneumonia, cytokine hyperproduction, and ARDS (2, 8, 10), and vitamin D was recently proposed as a repurposed drug for influenza A H5N1 virus-induced lung injury (3). Additionally, some studies suggest the effectiveness of vitamin D as an adjuvant therapy along with antiretroviral agents in HIV-infected patients (5). Furthermore, vitamin D pretreatment was beneficial in animal models of ARDS, reducing lung permeability by modulation of renin-angiotensin system activity and ACE2 expression (9). The role of vitamin D in the context of viral infections is also supported by findings of certain vitamin D receptor gene (VDR) alleles that are associated with increased susceptibility to respiratory infections (6), as well as with the progression of HIV infection (4).Owing to the lack of specific treatment and urgency to act, these findings could be tentatively extrapolated to SARS-CoV-2 infection, justifying the use of vitamin D as a possible adjuvant therapy. From the public health aspect, the recommendation of intensive supplementation as possible prophylaxis also could be considered. Given the good tolerability and safety of even high doses of vitamin D, this approach complies primum non nocere principle.Investigations on vitamin D status and VDR polymorphisms of affected subjects could contribute to explain "unusual behavior" of SARS-CoV-2 spreading and a tremendous variety of COVID-19 clinical presentations and outcomes.DISCLOSURESNo conflicts of interest, financial or otherwise, are declared by the author.AUTHOR CONTRIBUTIONSH.J. drafted manuscript; edited and revised manuscript; approved final version of manuscript.REFERENCES1. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res 7: 11, 2020. doi:10.1186/s40779-020-00240-0. Crossref | PubMed | ISI | Google Scholar2. Hong M, Xiong T, Huang J, Wu Y, Lin L, Zhang Z, Huang L, Gao D, Wang H, Kang C, Gao Q, Yang X, Yang N, Hao L. Association of vitamin D supplementation with respiratory tract infection in infants. Matern Child Nutr 5: e12987, 2020. doi:10.1111/mcn.12987. Crossref | PubMed | ISI | Google Scholar3. Huang F, Zhang C, Liu Q, Zhao Y, Zhang Y, Qin Y, Li X, Li C, Zhou C, Jin N, Jiang C. Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury. PLoS Pathog 16: e1008341, 2020. doi:10.1371/journal.ppat.1008341. Crossref | PubMed | ISI | Google Scholar4. Jiménez-Sousa MA, Jiménez JL, Fernández-Rodríguez A, Brochado-Kith O, Bellón JM, Gutierrez F, Díez C, Bernal-Morell E, Viciana P, Muñoz-Fernández MA, Resino S. VDR rs2228570 polymorphism is related to non-progression to AIDS in antiretroviral therapy naïve HIV-infected patients. J Clin Med 8: E311, 2019. doi:10.3390/jcm8030311. Crossref | PubMed | ISI | Google Scholar5. Jiménez-Sousa MÁ, Martínez I, Medrano LM, Fernández-Rodríguez A, Resino S. Vitamin D in human immunodeficiency virus infection: influence on immunity and disease. Front Immunol 9: 458, 2018. doi:10.3389/fimmu.2018.00458. Crossref | PubMed | ISI | Google Scholar6. Jolliffe DA, Greiller CL, Mein CA, Hoti M, Bakhsoliani E, Telcian AG, Simpson A, Barnes NC, Curtin JA, Custovic A, Johnston SL, Griffiths CJ, Walton RT, Martineau AR. Vitamin D receptor genotype influences risk of upper respiratory infection. Br J Nutr 120: 891–900, 2018. doi:10.1017/S000711451800209X. Crossref | PubMed | ISI | Google Scholar7. Teymoori-Rad M, Shokri F, Salimi V, Marashi SM. The interplay between vitamin D and viral infections. Rev Med Virol 29: e2032, 2019. doi:10.1002/rmv.2032. Crossref | PubMed | ISI | Google Scholar8. Tsujino I, Ushikoshi-Nakayama R, Yamazaki T, Matsumoto N, Saito I. Pulmonary activation of vitamin D3 and preventive effect against interstitial pneumonia. J Clin Biochem Nutr 65: 245–251, 2019. doi:10.3164/jcbn.19-48. Crossref | PubMed | ISI | Google Scholar9. Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep 16: 7432–7438, 2017. doi:10.3892/mmr.2017.7546. Crossref | PubMed | ISI | Google Scholar10. Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine (Baltimore) 98: e17252, 2019. doi:10.1097/MD.0000000000017252. Crossref | PubMed | ISI | Google ScholarAUTHOR NOTESCorrespondence: H. Jakovac (e-mail: hrvoje.jakovac@medri.uniri.hr). Download PDF Previous Back to Top FiguresReferencesRelatedInformation CollectionsAPS Cross-Journal CollectionsCoronavirus-Related Papers Related ArticlesReply to Jakovac: About COVID-19 and vitamin D 20 May 2020American Journal of Physiology-Endocrinology and MetabolismReply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective? 01 Jun 2020American Journal of Physiology-Endocrinology and MetabolismReply to Jakovac: "COVID-19 and vitamin D—Is there a link and an opportunity for intervention?" 17 Jun 2020American Journal of Physiology-Endocrinology and MetabolismReply to Jakovac: COVID-19, vitamin D, and type I interferon 16 Jul 2020American Journal of Physiology-Endocrinology and MetabolismReply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness? 13 Aug 2020American Journal of Physiology-Endocrinology and MetabolismCited ByAn overview on role of nutrition on COVID-19 immunity: Accumulative review from available studiesClinical Nutrition Open Science, Vol. 47Currently available COVID-19 management optionsVitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study20 August 2021 | Journal of Biomolecular Structure and Dynamics, Vol. 40, No. 22Medical students' knowledge about COVID-19 and evaluation of the effectiveness of the applied preventive strategies14 April 2022 | Archives of Public Health, Vol. 80, No. 1The Efficacious Benefit of 25-Hydroxy Vitamin D to Prevent COVID-19: An In-Silico Study Targeting SARS-CoV-2 Spike Protein23 November 2022 | Nutrients, Vol. 14, No. 23Vitamin D and morbidity in children with Multisystem inflammatory syndrome related to Covid-19Progress in Pediatric Cardiology, Vol. 66The effects of high dose vitamin D supplementation as a nutritional intervention strategy on biochemical and inflammatory factors in adults with COVID-19: Study protocol for a randomized controlled trial24 March 2022 | Nutrition and Health, Vol. 28, No. 3Vitamin D: A Potential Mitigation Tool for the Endemic Stage of the COVID-19 Pandemic?10 June 2022 | Frontiers in Public Health, Vol. 10Impact of Vitamin D Therapy on the Progress COVID-19: Six Weeks Follow-Up Study of Vitamin D Deficient Elderly Diabetes Patients1 September 2021 | Proceedings of Singapore Healthcare, Vol. 31Vitamin D supplementation and Covid‐19 outcomes: A systematic review, meta‐analysis and meta‐regression27 June 2021 | Reviews in Medical Virology, Vol. 32, No. 2Integrated Nutritional Supports for Diabetic Patients During COVID-19 Infection: A Comprehensive ReviewCurrent Diabetes Reviews, Vol. 18, No. 3COVID-19 HASTALIĞINI ÖNLEMEDE KULLANILAN TAKVİYE EDİCİ GIDALAR VE SAĞLIK ÜZERİNE ETKİLERİ28 February 2022 | GIDA / THE JOURNAL OF FOODThe Relationship Between Vitamin D Status and the Clinical Severity of COVID-19 Infection: A Retrospective Single-Center AnalysisCureus, Vol. 395Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy15 July 2021 | Expert Review of Anti-infective Therapy, Vol. 20, No. 2Short term, high-dose vitamin D supplementation for COVID-19 disease: a randomised, placebo-controlled, study (SHADE study)12 November 2020 | Postgraduate Medical Journal, Vol. 98, No. 1156Parkinson's Disease in Light of the COVID-19 Pandemic21 January 2022 | Brain Sciences, Vol. 12, No. 2The coronavirus disease (COVID-19) – A supportive approach with selected micronutrientsInternational Journal for Vitamin and Nutrition Research, Vol. 92, No. 1Vitamin D status of Arab Gulf residents screened for SARS-CoV-2 and its association with COVID-19 infection: a multi-centre case–control study26 April 2021 | Journal of Translational Medicine, Vol. 19, No. 1Current Overview on Therapeutic Potential of Vitamin D in Inflammatory Lung Diseases6 December 2021 | Biomedicines, Vol. 9, No. 12The latitude hypothesis, vitamin D, and SARS-Co-V217 July 2020 | Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 16Tanning-Elicited Variations in the Ultraviolet Absorption Spectra of the Cutaneous Tissues: Skin Photobiology and Photomedicine ImplicationsThe role of vitamin D in the age of COVID‐19: A systematic review and meta‐analysis6 August 2021 | International Journal of Clinical Practice, Vol. 75, No. 11Mineral metabolism and COVID-19: is there a connection?15 October 2021 | Terapevticheskii arkhiv, Vol. 93, No. 10Impact of vitamin D on the course of COVID-19 during pregnancy: A case control studyThe Journal of Steroid Biochemistry and Molecular Biology, Vol. 213Viral Infections, Including Influenza and Corona Virus Disease 2019, and Vitamin D: A Mini-Review15 September 2021Keeping a Balance During the Pandemic: a Narrative Review on the Important Role of Micronutrients in Preventing Infection and Reducing Complications of COVID-195 May 2021 | Current Nutrition Reports, Vol. 10, No. 3Serum 25-hydroxyvitamin D measurement: Comparative evaluation of three automated immunoassaysPractical Laboratory Medicine, Vol. 26Putative Role of Vitamin D for COVID-19 Vaccination20 August 2021 | International Journal of Molecular Sciences, Vol. 22, No. 16COVID-19 disease, obesity and micronutrients: an updated narrative review of the literature4 November 2020 | Nutrition & Food Science, Vol. 51, No. 5Detectable respiratory SARS‐CoV‐2 RNA is associated with low vitamin D levels and high social deprivation24 April 2021 | International Journal of Clinical Practice, Vol. 75, No. 7Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial24 June 2021 | Nutrients, Vol. 13, No. 7Dysregulated inflammation may predispose patients with serious mental illnesses to severe COVID‑19 (Review)28 June 2021 | Molecular Medicine Reports, Vol. 24, No. 2Potential benefits of dietary seaweeds as protection against COVID-1922 December 2020 | Nutrition Reviews, Vol. 79, No. 7Drug repurposing: new strategies for addressing COVID-19 outbreak3 December 2020 | Expert Review of Anti-infective Therapy, Vol. 19, No. 6Possible association of vitamin D status with lung involvement and outcome in patients with COVID-19: a retrospective study30 October 2020 | European Journal of Nutrition, Vol. 60, No. 4Vitamin D and COVID-19: is there a role?29 March 2021 | Journal of Diabetes & Metabolic Disorders, Vol. 20, No. 1Vitamin-D receptor (VDR) gene polymorphism (FokI) in Syrian healthy populationGene Reports, Vol. 23Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i)Immunotherapy, Vol. 13, No. 9Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approachWorld Journal of Virology, Vol. 10, No. 3Can Vitamin D Deficiency Increase the Susceptibility to COVID-19?21 May 2021 | Frontiers in Physiology, Vol. 12Vitamin D, Depressive Symptoms, and Covid-19 Pandemic13 May 2021 | Frontiers in Neuroscience, Vol. 15Association between vitamin D supplementation or serum vitamin D level and susceptibility to SARS-CoV-2 infection or COVID-19 including clinical course, morbidity and mortality outcomes? A systematic review28 May 2021 | BMJ Open, Vol. 11, No. 5Vitamin D and COVID‐19 in an immunocompromised patient with multiple comorbidities—A Case Report5 March 2021 | Clinical Case Reports, Vol. 9, No. 4The association between the level of serum 25(OH) vitamin D, obesity, and underlying diseases with the risk of developing COVID‐19 infection: A case–control study of hospitalized patients in Tehran, Iran29 December 2020 | Journal of Medical Virology, Vol. 93, No. 4Vitamin D and Covid‐19: From potential therapeutic effects to unanswered questions28 August 2020 | Reviews in Medical Virology, Vol. 31, No. 2Micronutrients and bioactive compounds in the immunological pathways related to SARS-CoV-2 (adults and elderly)21 October 2020 | European Journal of Nutrition, Vol. 60, No. 2Vitamin D and COVID‐19: It is time to act27 October 2020 | International Journal of Clinical Practice, Vol. 75, No. 3Candidate Formulations for a Sustainable Lipstick Supplemented with Vitamin D3: Effects of Wax Type and Concentration on Material Properties1 February 2021 | Industrial & Engineering Chemistry Research, Vol. 60, No. 5SARS-CoV-2 Therapy: Old Drugs as New InterventionsCoronaviruses, Vol. 2, No. 2COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?30 January 2021 | The North African Journal of Food and Nutrition Research, Vol. 4, No. 10SARS-CoV-2: influence of phosphate and magnesium, moderated by vitamin D, on energy (ATP) metabolism and on severity of COVID-19Theo A. T. G. van Kempen and Elisabeth Deixler10 January 2021 | American Journal of Physiology-Endocrinology and Metabolism, Vol. 320, No. 1Drug-Nutrition Interactions in Infectious Diseases11 December 2020Nutrition and Immunity in COVID-1911 May 2021Obesity, malnutrition, and trace element deficiency in the coronavirus disease (COVID-19) pandemic: An overviewNutrition, Vol. 81Prevalence and Clinical Outcomes of Vitamin D Deficiency in COVID-19 Hospitalized Patients: A Retrospective Single-Center AnalysisThe Tohoku Journal of Experimental Medicine, Vol. 255, No. 24R COVID-19 Toolkit for Patient Self-Management of Mild or Moderate COVID-19 symptomsSSRN Electronic Journal, Vol. 323Investigating the Potential for Ultraviolet Light to Modulate Morbidity and Mortality From COVID-19: A Narrative Review and Update23 December 2020 | Frontiers in Cardiovascular Medicine, Vol. 7Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics8 December 2020 | Frontiers in Cellular and Infection Microbiology, Vol. 10Vitamin D Update14 October 2020 | Current Dermatology Reports, Vol. 9, No. 4Prevalence of obesity and hypovitaminosis D in elderly with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical Nutrition ESPEN, Vol. 40Repurposing existing drugs for COVID-19: an endocrinology perspective29 September 2020 | BMC Endocrine Disorders, Vol. 20, No. 1Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic15 July 2020 | BMC Medicine, Vol. 18, No. 1Vitamin D and Covid-19: an update on evidence and potential therapeutic implications19 November 2020 | Clinical and Molecular Allergy, Vol. 18, No. 1High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study11 December 2020 | Nutrients, Vol. 12, No. 12Association Between Vitamin D and Novel SARS-CoV-2 Respiratory Dysfunction – A Scoping Review of Current Evidence and Its Implication for COVID-19 Pandemic26 November 2020 | Frontiers in Physiology, Vol. 11The role of vitamin D in seasonal acute respiratory viral infections and COVID-1915 November 2020 | Terapevticheskii arkhiv, Vol. 92, No. 11Sex differences in COVID-19 course and outcome: progesterone should not be neglectedHrvoje Jakovac23 October 2020 | Journal of Applied Physiology, Vol. 129, No. 5Food Ingredients and Active Compounds against the Coronavirus Disease (COVID-19) Pandemic: A Comprehensive Review20 November 2020 | Foods, Vol. 9, No. 11Vitamin D3 as Potential Treatment Adjuncts for COVID-1914 November 2020 | Nutrients, Vol. 12, No. 11Role of vitamin D in preventing of COVID-19 infection, progression and severityJournal of Infection and Public Health, Vol. 13, No. 10Vitamine D et risque des infections respiratoires aiguës : grippe et COVID-19Nutrition Clinique et Métabolisme, Vol. 34, No. 3The Role of Micronutrients in Support of the Immune Response against Viral Infections20 October 2020 | Nutrients, Vol. 12, No. 10Micronutrients in COVID-19 Positive PregnanciesCureus, Vol. 55A Basic Review of the Preliminary Evidence That COVID-19 Risk and Severity Is Increased in Vitamin D Deficiency10 September 2020 | Frontiers in Public Health, Vol. 8COVID‐19 and Vitamin D: A lesson from the skin9 September 2020 | Experimental Dermatology, Vol. 29, No. 9Low plasma 25(OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study28 August 2020 | The FEBS Journal, Vol. 287, No. 17An Update on Vitamin D Metabolism8 September 2020 | International Journal of Molecular Sciences, Vol. 21, No. 18Could Vitamins Help in the Fight Against COVID-19?23 August 2020 | Nutrients, Vol. 12, No. 9Vitamin D Deficiency and Outcome of COVID-19 Patients10 September 2020 | Nutrients, Vol. 12, No. 9Impact of Vitamin D Deficiency on COVID-19—A Prospective Analysis from the CovILD Registry11 September 2020 | Nutrients, Vol. 12, No. 9Antibiotic Effects of selected leaf extracts and molecular profile of Klebsiella pneumoniae and Enterobacter bugandensis strain (AdM2)5 August 2020 | Highlights in BioScienceReply to Jakovac: COVID-19, vitamin D, and type I interferonMaria Cristina Gauzzi and Laura Fantuzzi16 July 2020 | American Journal of Physiology-Endocrinology and Metabolism, Vol. 319, No. 2Reply to Jakovac and to Rocha et al.: Can vitamin D prevent or manage COVID-19 illness?Andrzej T. Slominski, Radomir M. Slominski, Paul A. Goepfert, Tae-Kang Kim, Michael F. Holick, Anton M. Jetten, and Chander Raman13 August 2020 | American Journal of Physiology-Endocrinology and Metabolism, Vol. 319, No. 2Elderly at time of COronaVIrus disease 2019 (COVID-19): possible role of immunosenescence and malnutrition23 June 2020 | GeroScience, Vol. 42, No. 4Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsJournal of Allergy and Clinical Immunology, Vol. 146, No. 2Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attackJournal of the Neurological Sciences, Vol. 415Reply to Jakovac: "COVID-19 and vitamin D—Is there a link and an opportunity for intervention?"Jung Hyun Kwak and Jean Kyung Paik17 June 2020 | American Journal of Physiology-Endocrinology and Metabolism, Vol. 319, No. 1COVID ‐19 in Parkinson's Disease Patients Living in Lombardy, Italy26 June 2020 | Movement Disorders, Vol. 35, No. 7Vitamin D concentrations and COVID-19 infection in UK BiobankDiabetes & Metabolic Syndrome: Clinical Research & Reviews, Vol. 14, No. 4Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns18 July 2020 | Journal of Clinical Medicine, Vol. 9, No. 7Reply to Jakovac: About COVID-19 and vitamin DAngelo Facchiano*, Antonio Facchiano*, Manuela Bartoli, Alberto Ricci, and Francesco Facchiano*20 May 2020 | American Journal of Physiology-Endocrinology and Metabolism, Vol. 318, No. 6Reply to Jakovac; Severity of COVID-19 infection in patients with phenylketonuria: is vitamin D status protective?Júlio César Rocha, Conceição Calhau, and Anita MacDonald1 June 2020 | American Journal of Physiology-Endocrinology and Metabolism, Vol. 318, No. 6Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson's Disease8 May 2020 | Brain Sciences, Vol. 10, No. 5COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation19 May 2020 | Nutrients, Vol. 12, No. 5Obesity, COVID-19 and vitamin D: is there an association worth examining?3 June 2020 | Advances in Obesity, Weight Management & Control, Vol. 10, No. 3Considerations for future novel human-infecting coronavirus outbreaks29 August 2020 | Surgical Neurology International, Vol. 11Infección por SARS-CoV-2 (COVID-19) en PediatríaRevista Latinoamericana de Infectología Pediátrica, Vol. 33, No. 4 More from this issue > Volume 318Issue 5May 2020Pages E589-E589 Copyright & PermissionsCopyright © 2020 the American Physiological Societyhttps://doi.org/10.1152/ajpendo.00138.2020PubMed32297519History Received 6 April 2020 Accepted 7 April 2020 Published online 16 April 2020 Published in print 1 May 2020 KeywordsARDSCOVID-19immunomodulationlung injurySARS-CoV-2vitamin D Metrics
Referência(s)